TREATMENT OF LIGHT CHAIN (AL) AMYLOIDOSIS WITH BORTEZOMIB AND DEXAMETASONE

被引：0
|
作者：
Canovas, A. [1 ]
Alonso, J. J. [1 ]
Barreiro, G. [1 ]
机构：
[1] Hosp Cruces, Bilbao, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1108
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [1] Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
    Kastritis, E.
    Anagnostopoulos, A.
    Roussou, M.
    Toumanidis, S.
    Pamboukas, C.
    Tassidou, A.
    Xilouri, I.
    Delibasi, S.
    Psimenou, E.
    Mellou, S.
    Terpos, E.
    Nanas, J.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 200 - 200
  • [2] Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
    Kastritis, Efstathios
    Anagnostopoulos, Athanasios
    Roussou, Maria
    Toumanidis, Savvas
    Pamboukas, Constantinos
    Migkou, Magdalini
    Tassidou, Anna
    Xilouri, Irini
    Delibasi, Sossana
    Psimenou, Erasmia
    Mellou, Sofia
    Terpos, Evangelos
    Nanas, John
    Dimopoulos, Meletios A.
    HAEMATOLOGICA, 2007, 92 (10) : 1351 - 1358
  • [3] Treatment of light chain (AL) amyloidosis and light chain deposition disease (LCDD) with the combination of Bortezomib and dexamethasone
    Kastritis, Efstathios
    Anagnostopoulos, Athanasios
    Roussou, Maria
    Toumanidis, Savvas
    Pamboukas, Constantinos
    Tassidou, Anna
    Xilouri, Irini
    Delimpassi, Sossana
    Psimenou, Erasmia
    Mellou, Sofia
    Terpos, Evangelos
    Nanas, John
    Dimopoulos, Meletios Athanasios
    BLOOD, 2007, 110 (11) : 64A - 64A
  • [4] Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)
    Kastritis, Efstathios
    Dialoupi, Ioanna
    Gavriatopoulou, Maria
    Roussou, Maria
    Kanellias, Nikolaos
    Fotiou, Despina
    Ntanasis-Stathopoulos, Ioannis
    Papadopoulou, Elektra
    Ziogas, Dimitrios C.
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Ntalianis, Argyrios
    Eleutherakis-Papaiakovou, Evangelos
    Papanikolaou, Asimina
    Migkou, Magdalini
    Gakiopoulou, Charikleia
    Psimenou, Erasmia
    Tselegkidi, Marini
    Tsitsilonis, Ourania
    Trougakos, Ioannis
    Kostopoulos, Ioannis
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S331 - S332
  • [5] Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)
    Kastritis, Eftathios
    Dialoupi, Ioanna
    Gavriatopoulou, Maria
    Roussou, Maria
    Kanellias, Nikolaos
    Tselegkidi, Marini
    Papadopoulou, Elektra
    Ziogas, Dimitrios C.
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Ntalianis, Argyrios
    Eleutherakis-Papaiakovou, Evangelos
    Migkou, Magdalini
    Despina, Fotiou
    Papanikolaou, Asimina
    Gakiopoulou, Charikleia
    Psimenou, Erasmia
    Tatouli, Ioanna
    Ntanasis-Stathopoulos, Ioannis
    Bagratuni, Tina
    Papathoma, Alexandra
    Spyropoulou-Vlachou, Marilyn
    Giannouli, Stavroula
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2018, 132
  • [6] Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD)
    Huang, B.
    Li, J.
    Xu, X.
    Zheng, D.
    Zhou, Z.
    Liu, J.
    PATHOLOGIE BIOLOGIE, 2015, 63 (01): : 17 - 20
  • [7] Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
    Kastritis, Efstathios
    Dialoupi, Ioanna
    Gavriatopoulou, Maria
    Roussou, Maria
    Kanellias, Nikolaos
    Fotiou, Despina
    Ntanasis-Stathopoulos, Ioannis
    Papadopoulou, Elektra
    Ziogas, Dimitrios C.
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Ntalianis, Argyrios
    Eleutherakis-Papaiakovou, Evangelos
    Papanikolaou, Asimina
    Migkou, Magdalini
    Papanota, Aristea-Maria
    Gakiopoulou, Harikleia
    Psimenou, Erasmia
    Tselegkidi, Maria Irini
    Tsitsilonis, Ourania
    Kostopoulos, Ioannis
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD ADVANCES, 2019, 3 (20) : 3002 - 3009
  • [8] Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Fotiou, Despina
    Kanellias, Nikolaos
    Migkou, Magdalini
    Tselegkidi, Maria Irini
    Marinaki, Smaragdi
    Psimenou, Erasmia
    Ntanasis-Stathopoulos, Ioannis
    Gakiopoulou, Harikleia
    Papanota, Aristea-Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E320 - E321
  • [9] Treatment of Immunoglobulin Light Chain (Primary or AL) Amyloidosis
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    ONCOLOGY-NEW YORK, 2011, 25 (07): : 620 - 626
  • [10] Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
    Palladini, Giovanni
    Milani, Paolo
    Malavasi, Fabio
    Merlini, Giampaolo
    CELLS, 2021, 10 (03) : 1 - 11
12345